{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Achy-Brou AC"],"funding":["NIDA NIH HHS","NIAID NIH HHS","NIMH NIH HHS"],"pagination":["824-33"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4593705"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["66(3)"],"pubmed_abstract":["We derive regression estimators that can compare longitudinal treatments using only the longitudinal propensity scores as regressors. These estimators, which assume knowledge of the variables used in the treatment assignment, are important for reducing the large dimension of covariates for two reasons. First, if the regression models on the longitudinal propensity scores are correct, then our estimators share advantages of correctly specified model-based estimators, a benefit not shared by estimators based on weights alone. Second, if the models are incorrect, the misspecification can be more easily limited through model checking than with models based on the full covariates. Thus, our estimators can also be better when used in place of the regression on the full covariates. We use our methods to compare longitudinal treatments for type II diabetes mellitus."],"journal":["Biometrics"],"pubmed_title":["Estimating treatment effects of longitudinal designs using regression models on propensity scores."],"pmcid":["PMC4593705"],"funding_grant_id":["R01 DA023879-01","R01DA023879-01","R01 DA023879","P30MH066247","5R01AI078835"],"pubmed_authors":["Achy-Brou AC","Griswold M","Frangakis CE"],"additional_accession":[]},"is_claimable":false,"name":"Estimating treatment effects of longitudinal designs using regression models on propensity scores.","description":"We derive regression estimators that can compare longitudinal treatments using only the longitudinal propensity scores as regressors. These estimators, which assume knowledge of the variables used in the treatment assignment, are important for reducing the large dimension of covariates for two reasons. First, if the regression models on the longitudinal propensity scores are correct, then our estimators share advantages of correctly specified model-based estimators, a benefit not shared by estimators based on weights alone. Second, if the models are incorrect, the misspecification can be more easily limited through model checking than with models based on the full covariates. Thus, our estimators can also be better when used in place of the regression on the full covariates. We use our methods to compare longitudinal treatments for type II diabetes mellitus.","dates":{"release":"2010-01-01T00:00:00Z","publication":"2010 Sep","modification":"2020-10-29T13:14:36Z","creation":"2019-03-27T01:59:31Z"},"accession":"S-EPMC4593705","cross_references":{"pubmed":["19817741"],"doi":["10.1111/j.1541-0420.2009.01334.x"]}}